US 12,236,595 B2
Characterizing permeability, neovascularization, necrosis, collagen breakdown, or inflammation
Andrew J. Buckler, Boston, MA (US); Kjell Johnson, Ann Arbor, MI (US); Xiaonan Ma, South Hamilton, MA (US); Keith A. Moulton, Amesbury, MA (US); and David S. Paik, Boston, MA (US)
Assigned to ELUCID BIOIMAGING INC., Boston, MA (US)
Filed by ELUCID BIOIMAGING INC., Boston, MA (US)
Filed on Dec. 19, 2023, as Appl. No. 18/545,550.
Application 18/545,550 is a division of application No. 18/307,316, filed on Apr. 26, 2023.
Application 18/307,316 is a continuation of application No. 17/328,414, filed on May 24, 2021, granted, now 11,676,359, issued on Jun. 13, 2023.
Application 17/328,414 is a continuation of application No. 16/203,418, filed on Nov. 28, 2018, granted, now 11,094,058, issued on Aug. 17, 2021.
Application 16/203,418 is a continuation in part of application No. 14/959,732, filed on Dec. 4, 2015, granted, now 10,176,408, issued on Jan. 8, 2021.
Claims priority of provisional application 62/771,448, filed on Nov. 26, 2018.
Claims priority of provisional application 62/676,975, filed on May 27, 2018.
Claims priority of provisional application 62/219,860, filed on Sep. 17, 2015.
Claims priority of provisional application 62/205,295, filed on Aug. 14, 2015.
Claims priority of provisional application 62/205,313, filed on Aug. 14, 2015.
Claims priority of provisional application 62/205,305, filed on Aug. 14, 2015.
Claims priority of provisional application 62/205,322, filed on Aug. 14, 2015.
Prior Publication US 2024/0161296 A1, May 16, 2024
Int. Cl. G06T 7/00 (2017.01); G06F 18/211 (2023.01); G06F 18/214 (2023.01); G06F 18/24 (2023.01); G06N 3/08 (2023.01); G06N 20/00 (2019.01); G06T 3/00 (2006.01); G06T 5/73 (2024.01); G06T 7/11 (2017.01); G06V 10/25 (2022.01); G06V 10/764 (2022.01); G06V 20/69 (2022.01)
CPC G06T 7/0012 (2013.01) [G06F 18/211 (2023.01); G06F 18/2148 (2023.01); G06F 18/24 (2023.01); G06N 3/08 (2013.01); G06N 20/00 (2019.01); G06T 3/00 (2013.01); G06T 5/73 (2024.01); G06T 7/11 (2017.01); G06V 10/25 (2022.01); G06V 10/764 (2022.01); G06V 20/69 (2022.01); G06T 2207/10048 (2013.01); G06T 2207/10081 (2013.01); G06T 2207/10088 (2013.01); G06T 2207/10101 (2013.01); G06T 2207/10104 (2013.01); G06T 2207/10108 (2013.01); G06T 2207/10132 (2013.01); G06T 2207/20081 (2013.01); G06T 2207/30096 (2013.01); G06T 2207/30104 (2013.01)] 12 Claims
OG exemplary drawing
 
1. A system for implementing a layered analytics framework, the system comprising:
a processor configured to:
receive imaging data of Computed Tomography (CT), Magnetic resonance (MR), Ultrasound (US), or Positron Emission Tomography (PET) of a patient, imaged at two or more points in time;
for each of the points in time, determine, based on the received imaging data at each respective point in time, a set of segmentations including lumen, wall, or a combination thereof, wherein the set of segmentation includes one or more cross sectional slices of a vessel;
determine, based on the set of segmentations, a change in a set of quantities that identify or characterize permeability, neovascularization, necrosis, collagen breakdown, or inflammation, across the points in time; and
output the identification or characterization of the permeability, neovascularization, necrosis, collagen breakdown, or inflammation for each of the points in time.